Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy

Leukemia Research

Volumn 24, Issue 4, 2000, Pages 339-347

  Formánková, Renata ^a,b   Honzátková, Lenka ^a   Moravcová, Jana ^a   Sieglová, Zuzana ^a   Dvořáková, Renata ^a   Nádvorníková, Sylvie ^a   Vítek, Antonín ^a   Lukášová, Marcela ^a   Starý, Jan ^b   Brdička, Radim ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BCR ABL; Bone marrow transplantation; Chronic myeloid leukemia; Donor; Minimal residual disease; Mixed chimerism; Relapse

Indexed keywords

INTERFERON; MESSENGER RNA;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHIMERA; DISEASE-FREE SURVIVAL; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0342632837     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00185-X     Document Type: Article

References (32)

1. Goldman J.M., Apperley J.F., Marcus R., Goolden A.W.G., Batchelor R., Hale G., Waldmann H., Reid C.D., Hows J., Gordon-Smith E., Cathovsky D., Galton D.A.G. Bone marrow transplantation for patients with chronic myeloid leukemia. New Engl. J. Med. 314:1986;202.
2. Radisch J.P., Gehly G., Gooley T., Bryant E., Clift R.A., Collins S., Edmands S., Kirk J., Lee A., Kessler P. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood. 85:1995;2632.
3. Cross N.C.P., Hughes T.P., Lin F., Feng L., O'Shea P., Bungey J., Marks D.I., Ferrant A., Martiat P., Goldman J.M. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute-graft versus-host disease and relapse. Br. J. Haematol. 84:1993;67.
4. Hochhaus A., Lin F., Reiter A., Skladny H., Mason P.J., van Rhee F., Stepherd P.C., Allan N.C., Hehlmann R., Goldman J.M., Cross N.C. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood. 87:1996;1549.
5. Lion T. Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplant. 14:1994;505.
6. Moravcová J., Lukášová M., Starý J., Haškovec C. Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation. Leukemia. 12:1998;1303.
7. Browne P.V., Lawrer M., ORiordan J., Humphries P., McCann S.R. Early detection of leukaemic relapse after bone marrow transplantation using the polymerase chain reaction. Bone Marrow Transplant. 7:1991;167.
8. McCann S.R., Lawrer M. Mixed chimerism; detection and significance following BMT. Bone Marrow Transplant. 11:1993;91.
9. Socie G., Lawrer M., Gluckman E., McCann S.R., Brison O. Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology area. Leuk. Res. 19:1995;497.
10. Suttorp M., Schmitz N., Dreger P., Schaub J., Loffler H. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. Leukemia. 7:1993;679.
11. Elmaagacli A.H., Beelen D.W., Becks H.W., Mobascher A., Stockova J., Trzensky S., Opalka B., Schaefer U.W. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cells or bone marrow transplantation. Bone Marrow Transplant. 18:1996;397.
12. Mackinnon S., Barnett L., Heller G., O'Reilly R.J. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood. 83:1994;3409.
13. Bader P., Beck J., Frey A., Schlegel P.G., Hebarth H., Handgretinger R., Einsele H., Niemeyer H., Benda N., Faul C., Kanz L., Niethammer D., Klingebiel T. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant. 21:1998;487.
14. Chalmers E.A., Sproul A.M., Mills K.I., Gibson B.E.S., Burnett A.K. Use of polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation. Bone Marrow Transplant. 6:1990;399.
15. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 85:1988;1215.
16. Guistincich S, Manfioletti G, Del Sal G. A fast method for high-quality genomic DNA extraction from whole human blood. BioTechnique 1991;11:298.
17. Boerwinkle E., Xiong W., Fourest E., Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′hypervariable region. Genetics. 86:1989;212-216.
18. Wu S., Seino S., Bell G.I. Human collagen, type II, alpha 1 (Col2A1) gene: VNTR polymorphism detected by gene amplification. Nucleic Acids Res. 18:1990;3102-3103.
19. Horn G.T., Richards B., Klinger K.W. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res. 17:1989;2140.
20. Kasai K., Nakamura Y., White R. Amplification of a variable number of tandem repats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J. Forensic Sci. 35:1990;1196.
21. Decorte R., Cuppens H., Marynen P., Cassiman J.J. Rapid detection of hypervariable regions by the polymerase chain reaction technique. DNA. Cell Biol. 9:1990;461.
22. Nakahori I., Hamano K., Iwaya M., Nakagome Y. Sex identification by polymerase chain reaction using X-Y homologous primer. Am. J. Med. Gen. 39:1991;472.
23. Lo Y.-M.D., Wanscoat J.S., Gillmer M.D.G., Patel P., Sampietro M., Fleming K.A. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet. 9:1989;1363.
24. Ramírez M., Díaz M.A., García-Sánchez F., Velasco M., Casado F., Villa M., Vicario J.L., Madero L. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Bone Marrow Transplant. 18:1996;1161.
25. Helg C., Roux E., Beris P., Cabrol C., Wacker P., Darbellay R., Wyss M., Jeannet M., Chapuis B., Roosnek E. Adoptive immunotherapy for recurrent CML after BMT. Bone Marrow Transplant. 12:1993;125.
26. Helg C., Starobinski M., Jeannet M., Chapuis B. Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. Leuk. Lymph. 29:1998;301.
27. Verdonck L.F., Petersen E.J., Lokhorst H.M., Nieuwenhuis H.K., Dekker A.W., Tilanus M.G.J., de Wegwr R.A. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T-cells. Bone Marrow Transplant. 22:1998;1057.
28. Kolb HJ, Schattenberg A, Goldman JM, Hartenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rheo F, Mittermueller J, de Witte T, Holler E, Ansari H for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus leukemia effect of donor lymphocyte infusion in marrow grafted patients. Blood 1995;86:2041.
29. Román J., Martín C., Torres A., García A., Andrés P., García M.J., Baiget M. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long term survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia. Leuk. Lymph. 28:1998;541.
30. Gardiner N., Lawrer M., O'Riordian J., DeArce M., Humphries P., McCann S.R. Persistent donor chimaerism is consistent with disease free survival following BMT for chronic myeloid leukemia. Bone Marrow Transplant. 20:1997;235.
31. van Rhee F., Lin F., Cullis J.O., Spencer A., Cross N.C., Chase A., Garicochea B., Bungey J., Barrett J., Goldman J.M. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood. 83:1994;3377.
32. Rapanotti MC, Arcese W, Buffolino, Iori AP, Mengarelli A, De Cuia MR, Cardillo A, Cimino G. Sequential monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation. Bone Marrow Transplant 1997;19:703.